BRL 26.17
(-1.91%)
Year | Net Income | Net Income Growth |
---|---|---|
2023 | 2.04 Billion BRL | 70.78% |
2022 | 1.19 Billion BRL | -24.14% |
2021 | 1.57 Billion BRL | 267.78% |
2020 | 428.32 Million BRL | -63.3% |
2019 | 1.16 Billion BRL | -0.25% |
2018 | 1.16 Billion BRL | 22.63% |
2017 | 954.02 Million BRL | 18.97% |
2016 | 801.87 Million BRL | 10.64% |
2015 | 724.73 Million BRL | 126.34% |
2014 | 320.19 Million BRL | 53.72% |
2013 | 208.29 Million BRL | 0.0% |
Year | Net Income | Net Income Growth |
---|---|---|
2024 Q1 | 804.59 Million BRL | 36.16% |
2024 Q2 | 971.65 Million BRL | 20.76% |
2023 FY | 2.04 Billion BRL | 70.78% |
2023 Q1 | 298.69 Million BRL | 10.77% |
2023 Q3 | 753.84 Million BRL | 84.53% |
2023 Q4 | 590.91 Million BRL | -21.61% |
2023 Q2 | 408.52 Million BRL | 36.77% |
2022 Q2 | 339.41 Million BRL | 61.19% |
2022 Q3 | 375.32 Million BRL | 10.58% |
2022 FY | 1.19 Billion BRL | -24.14% |
2022 Q1 | 210.57 Million BRL | -48.19% |
2022 Q4 | 269.65 Million BRL | -28.15% |
2021 Q3 | 350.96 Million BRL | -21.23% |
2021 Q2 | 445.53 Million BRL | 19.64% |
2021 Q1 | 372.4 Million BRL | 33.7% |
2021 Q4 | 406.4 Million BRL | 15.8% |
2021 FY | 1.57 Billion BRL | 267.78% |
2020 Q1 | 110.46 Million BRL | -60.24% |
2020 Q3 | 337.9 Million BRL | 213.17% |
2020 Q2 | -298.57 Million BRL | -370.28% |
2020 Q4 | 278.53 Million BRL | -17.57% |
2020 FY | 428.32 Million BRL | -63.3% |
2019 Q3 | 265.14 Million BRL | -27.8% |
2019 FY | 1.16 Billion BRL | -0.25% |
2019 Q4 | 277.84 Million BRL | 4.79% |
2019 Q2 | 367.24 Million BRL | 42.99% |
2019 Q1 | 256.83 Million BRL | -8.66% |
2018 Q3 | 342.28 Million BRL | 0.82% |
2018 Q2 | 339.49 Million BRL | 64.01% |
2018 Q1 | 206.99 Million BRL | 27.52% |
2018 FY | 1.16 Billion BRL | 22.63% |
2018 Q4 | 281.19 Million BRL | -17.85% |
2017 Q1 | 205.96 Million BRL | 104.75% |
2017 Q2 | 276.96 Million BRL | 34.47% |
2017 Q3 | 308.77 Million BRL | 11.49% |
2017 Q4 | 162.32 Million BRL | -47.43% |
2017 FY | 954.02 Million BRL | 18.97% |
2016 Q3 | 196.31 Million BRL | -37.95% |
2016 FY | 801.87 Million BRL | 10.64% |
2016 Q2 | 316.37 Million BRL | 67.75% |
2016 Q4 | 100.59 Million BRL | -48.76% |
2016 Q1 | 188.59 Million BRL | -16.31% |
2015 Q3 | 203.35 Million BRL | -0.53% |
2015 FY | 724.73 Million BRL | 126.34% |
2015 Q2 | 204.43 Million BRL | 123.22% |
2015 Q1 | 91.58 Million BRL | -19.04% |
2015 Q4 | 225.35 Million BRL | 10.82% |
2014 Q1 | 22.45 Million BRL | 0.0% |
2014 Q4 | 113.12 Million BRL | 23.43% |
2014 Q3 | 91.65 Million BRL | -1.41% |
2014 FY | 320.19 Million BRL | 53.72% |
2014 Q2 | 92.95 Million BRL | 313.91% |
2013 FY | 208.29 Million BRL | 0.0% |
Name | Net Income | Net Income Difference |
---|---|---|
Kora Saúde Participações S.A. | -167.62 Million BRL | 1317.44% |
Oncoclínicas do Brasil Serviços Médicos S.A. | 223.61 Million BRL | -812.593% |